Heterogeneity of PD-MCI in Candidates to Subthalamic Deep Brain Stimulation: Associated Cortical and Subcortical

Quentin Devignes1, Sami Daoudi1, Romain Viard2

  • 1Univ. Lille, Inserm, Lille Neurosciences and Cognition, CHU-Lille, Neurology and Movement Disorders department, NS-Park/F-CRIN, Lille, France.

Abstract

Insights

Mild cognitive impairment in Parkinson's disease (PD-MCI) is common in patients undergoing subthalamic deep brain stimulation (STN-DBS). PD-MCI is linked to brain changes, with some subtypes facing higher dementia risk.

Area of Science:

  • Neuroscience
  • Neurology
  • Medical Imaging

Background:

  • Parkinson's disease mild cognitive impairment (PD-MCI) is prevalent and heterogeneous.
  • Its impact on subthalamic deep brain stimulation (STN-DBS) outcomes remains unclear.

Purpose of the Study:

  • Determine PD-MCI prevalence and subtypes in STN-DBS candidates.
  • Identify MRI markers associated with cognitive impairment in PD-MCI subtypes.

Main Methods:

  • Utilized baseline data from the PREDISTIM cohort (320 patients).
  • Classified patients into normal cognition (PD-NC) or PD-MCI (frontostriatal - PD-FS, posterior cortical - PD-PC).
  • Performed comparative analyses of demographic, clinical, and T1-weighted MRI data.

Main Results:

  • 153/320 (48%) patients had PD-MCI, with 123 (80%) classified as PD-FS and 30 (20%) as PD-PC.
  • PD-PC patients showed lower global efficiency and poorer visuospatial, memory, and language performance.
  • PD-MCI patients exhibited cortical thinning and altered left caudate nucleus and hippocampus on MRI compared to PD-NC.

Conclusions:

  • A significant portion of STN-DBS candidates have PD-MCI, associated with cortical and subcortical alterations.
  • The PD-PC subtype, characterized by posterior cortical deficits, may indicate a higher risk for dementia progression.

Related Concept Videos